Sign Out
Hypertension: Treatment of essential hypertension in adults.
Cardiovascular risk reduction: Telmisartan is indicated for the reduction of the risk of myocardial infarction, stroke, or death from cardiovascular causes in patients 55 years of age or older at high risk of developing major cardiovascular events who are unable to take ACE inhibitors.
Studies of Telmisartan in this setting do not exclude that it may not preserve a meaningful fraction of the effect of the ACE inhibitor to which it was compared. Consider using the ACE inhibitor first, and, if it is stopped for cough only, consider re-typing the ACE inhibitor after the cough resolves.
Use of telmisartan with an ACE inhibitor is not recommended.
